• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FISHER SCIENTIFIC CO., LLC. SENSITITRE ARIS; INSTRUMENT FOR AUTO READER & INTERPRETATION OF OVERNIGHT SUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FISHER SCIENTIFIC CO., LLC. SENSITITRE ARIS; INSTRUMENT FOR AUTO READER & INTERPRETATION OF OVERNIGHT SUS Back to Search Results
Model Number TREK SENSITITRE ARIS
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Event Description
Four enterococcus isolates (including one cap isolate) tested false susceptible to high-level gentamicin (500 ug/ml).Thermo fisher has undertaken multiple attempts to identify the issue including servicing of the nephelometers for organism concentration, servicing of the instrument for temperature and optical performance, and reagent lot-to-lot variation.Testing of isolates by thermo fisher staff on our instruments revealed false susceptible results.Investigation was initiated late summer of 2014.Initial testing of all four isolates at thermo fisher facility on their instruments demonstrated resistance; however, further testing of the isolates at their facility on their instruments gave variable results of sensitive or resistant.At present, due to the very major errors identified, we cannot use sensititre for high-level gentamicin testing and are awaiting a practical resolution of this problem from thermo fisher.For the cap isolate, 997 laboratories reported high-level gentamicin by broth or agar dilution; 885 (98.7%) laboratories reported the result correctly as resistant.The consequence to the laboratory of these very major errors includes additional offline testing via disk diffusion for high-level gentamicin for all enterococcus isolates for clinical reporting.The device may have contributed to: potential patient harm through the reporting of false susceptible high-level gentamicin results.Manufacturer response for laboratory instrument, trek sensititre aris (per site reporter).
=
thermo fisher has undertaken multiple attempts to identify the issue including servicing of the nephelometers for organism concentration, servicing of the instrument for temperature and optical performance, and reagent lot-to-lot variation.Testing of isolates by thermo fisher staff on our instruments revealed false susceptible results.Investigation was initiated late summer of 2014.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SENSITITRE ARIS
Type of Device
INSTRUMENT FOR AUTO READER & INTERPRETATION OF OVERNIGHT SUS
Manufacturer (Section D)
FISHER SCIENTIFIC CO., LLC.
one reagent ln.
fair lawn NJ 07410
MDR Report Key4373729
MDR Text Key15963735
Report Number4373729
Device Sequence Number1
Product Code JWY
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Type of Report Initial
Report Date 12/22/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Invalid Data
Device Model NumberTREK SENSITITRE ARIS
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA12/22/2014
Event Location Hospital
Date Report to Manufacturer12/31/2014
Patient Sequence Number1
-
-